General
Release from Cairo Pharmaceuticals (CPCI.CA) Concerning the Board of Directors & the Executive Managers
Published at 28 April 2026 at 15:54Cairo PharmaceuticalsRelated stock:Cairo Pharmaceuticals stockAll Cairo Pharmaceuticals disclosures
Disclosure summary
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Release from the company concerning the Board of Directors & the Executive Managers.
Release from the Company (745 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Release from the company concerning the Board of Directors & the Executive Managers.
Release from the Company (745 KB)